Previous 10 | Next 10 |
home / stock / inno:cc / inno:cc news
Innocan Pharma Announces Clinical Study Results: Evidence of Reduced Osteoarthritis Pain in Dogs After Liposomal CBD Injection Canada NewsWire HERZLIYA, Israel and CALGARY, AB , Aug. 29, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OT...
Innocan Pharma Reports Q2 2023 Results Including US$2.706M Increase in Revenues Compared to Q2, 2022 Canada NewsWire US$3.121M Revenues for Q2, 2023 compared to US$415,000 for Q2 2022, representing an increase of 652% US$2.656M Gross Profit for Q2, 2023 compare...
Innocan Pharma Reports Q1 2023 Results including US$1.3M Increase in Revenues Compared to Q1 2022 Canada NewsWire USD 1.4M Gross Profit, compared to USD 78K last year USD 4.1M Cash Balance along the entire corporate structure USD 1.3M Increase in Revenu...
Innocan Pharma Reports Success in a Pre-Clinical Trial of a Liposomal-CBD Injection on a Paralyzed Goat Canada NewsWire HERZLIYA, Israel and CALGARY, Alberta , May 8, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company...
Innocan Pharma Reports Annual 2022 Results with USD 2.6M in Revenue Canada NewsWire HERZLIYA, Israel and CALGARY, Alberta , April 18, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") a pharmaceutical te...
Innocan Reports Novel Cannabinoid Delivery Platform Patent Application Canada NewsWire The application pertains to the development of a novel platform for loading Cannabinoids on Exosomes HERZLIYA, Israel and CALGARY, AB , April 3, 2023 /CNW/ -- Innoc...
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 23, 2023) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on developing innovative wellness products, announced today the successful results ...
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 17, 2023) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies and owner of a propri...
This is the first fully granted patent of Innocan in the United States The Patent covers Innocan's proprietary cannabis-based pain relief topical This serves as an indication of Innocan's growing intellectual property portfolio Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 1...
"Lady", an 11-year-old female dog was presented to Innocan labs suffering from severe autoimmune mediated polyarthritis. Lady was treated with Glycoflex, steroids, and hydrotherapy, but still suffered pain and had difficulty walking more than a few steps. Lady was administered Innocan's liposom...
News, Short Squeeze, Breakout and More Instantly...
Innocan Pharma Corporation - Common Shares Company Name:
INNO:CC Stock Symbol:
CNQC Market:
Innocan Pharma Announces Successful Preliminary Safety Evaluation of LPT-CBD in Minipigs Canada NewsWire HERZLIYA, Israel and CALGARY, AB , June 11, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a...
Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6.8 Million Canada NewsWire HERZLIYA, Israel and CALGARY, AB , May 27, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan...
FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain Canada NewsWire The regulatory approval process with the U.S. Food and Drug Administration has commenced for Innocan's LPT-CBD release technology, marking a key step in the advancement of non-opioid pai...